GLOBAL PREVENTIVE HEALTHCARE TECHNOLOGIES AND SERVICES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

The global preventive healthcare technologies and services market is estimated to be valued at USD 275.29 Bn in 2024 and is expected to exhibit a CAGR of 10.6% during the forecast period (2024-2031). The global preventive healthcare technologies and services market has been witnessing significant growth in recent years. Preventive healthcare aims to prevent diseases, conditions or injuries and promote good health. Advancements in technologies and growing focus on population health management have expanded the scope of preventive care. Various technologies such as imaging, advanced biomarkers, and genetics have enabled early detection and risk assessment of diseases. In addition, the widespread adoption of digital health solutions is supporting remote monitoring and facilitating access to preventive services. As the prevalence of chronic diseases rises worldwide, the demand for preventive interventions is growing exponentially. This has prompted investments into the development of innovative preventive healthcare models and measures. The market is expected to grow substantially in the coming years as focus on prevention gains more prominence.

Market Dynamics:

Rising incidence of lifestyle diseases, growing geriatric population susceptible to chronic illnesses and increasing healthcare costs associated with treatment are driving the demand for preventive healthcare technologies and services. Various government programmes aimed at population health are also boosting the adoption of these solutions. However, high investment requirements for the deployment of advanced preventive technologies and services act as a restraint. Developing affordable preventive solutions represents an opportunity for market players. Integrating cutting-edge technologies, such as artificial intelligence, also holds potential to revolutionize preventive care.

Key Features of the Study:

• This report provides an in-depth analysis of the global preventive healthcare technologies and services market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global preventive healthcare technologies and services market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this includes Healthlane, Abbott , GSK plc, Myriad Genetics, Omron Healthcare Inc., Quest Diagnostics, Pfizer, Inc., Merck & Co., Inc., Omnicell , Novx Systems, Corp., U-Systems, Ltd., Viatronix, Inc., Scripto LLC , Lifecom, Inc., Dilon Medical Technologies, Inc., and McKesson Corporation.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global preventive healthcare technologies and services market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global preventive healthcare technologies and services market.

Detailed Segmentation-

• By Service Type:
  • Diagnostic Services
  • Wellness & Health Assessment Services
  • Telemedicine Services
  • Pharmacy Services
  • Others
• By Technology Type:
  • Telemedicine
  • mHealth
  • Health Information Technology
  • Wearable Devices
  • Others
• By End User:
  • Healthcare Providers
  • Healthcare Payers
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa

Company Profiles:

• Healthlane
• Abbott 
• GSK plc
• Myriad Genetics
• Omron Healthcare Inc.
• Quest Diagnostics
• Pfizer, Inc.
• Merck & Co., Inc.
• Omnicell 
• Novx Systems, Corp.
• U-Systems, Ltd.
• Viatronix, Inc.
• Scripto LLC 
• Lifecom, Inc.
• Dilon Medical Technologies, Inc.
• McKesson Corporation